Daré Bioscience, Inc.
Clinical trials sponsored by Daré Bioscience, Inc., explained in plain language.
-
Could a vaginal capsule wipe out persistent HPV?
Disease control Not yet recruitingThis study tests whether DARE-HPV, a vaginal capsule containing HIV drugs lopinavir and ritonavir, can clear persistent high-risk HPV infections in women aged 22-50. Participants will receive one of two doses for 14 or 21 days, or a placebo. The main goal is to see if the infecti…
Phase: PHASE2 • Sponsor: Daré Bioscience, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New vaginal ring could make preterm birth prevention easier
Disease control Not yet recruitingThis early-stage study tests a new progesterone vaginal ring (8mg or 12mg daily) against a standard progesterone insert (100mg) in 60 healthy postmenopausal women. Researchers will measure how much progesterone gets into the blood over 14 days. The goal is to see if the ring deli…
Phase: PHASE1 • Sponsor: Daré Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC